跳至主要内容
临床试验/NCT02431741
NCT02431741已完成不适用

Title: A Prospective, Open, Non-controlled Clinical Investigation to Evaluate the Performance and Safety of an Antimicrobial Foam Transferring Dressing in Patients With Malignant Wounds

Molnlycke Health Care AB2 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2014年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
14
试验地点
2
主要终点
Infection in the Wound (Signs of Clinical Infection)

研究概览

简要总结

This is a prospective, open, non-controlled clinical investigation to evaluate the performance and safety of using Mepilex Transfer Ag on a malignant wound. Approximately ten to fifteen (10-15) subjects from one to three centers in Europe, presenting with a malignant (fungating) wound will be enrolled into the study. Eligible subjects will have one malignant (fungating) wound selected as a "study site". Subjects will be followed for a one-week observation period with their existing product followed by a 4-week investigation period using Mepilex Transfer Ag.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Presence of at least one exuding malignant (fungating) wound in need for antimicrobial treatment
  • Both genders with an age ≥ 18 years at randomization
  • Subjects with a suspected survival time of > 3 months
  • Signed informed consent

排除标准

  • Any known or suspected systemic infection
  • Use of metronidazole is not allowed during the investigation period
  • Any known sensitivity to silver or other components/products used in this study.
  • Major uncontrolled systemic disorders such as hepatic, renal, neurologic, or endocrinologic disorders.
  • Participation in another investigational study while participating in this study.

结局指标

主要结局

Infection in the Wound (Signs of Clinical Infection)

时间窗: weekly, for 5 weeks

Weekly Visual inspection of the wounds by the investigators.

次要结局

未报告次要终点

研究者

发起方
Molnlycke Health Care AB
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验